DermTech, Inc.

Informe acción OTCPK:DMTK.Q

Capitalización de mercado: US$3.8m

DermTech Dirección

Dirección controles de criterios 1/4

El CEO de DermTech's es Bret Christensen , nombrado en May 2023, tiene una permanencia de 1.08 años. compensación anual total es $1.93M, compuesta por 20.2% salario y 79.8% primas, incluidas acciones y opciones de la empresa. posee directamente un 0.007% de las acciones de la empresa, por valor de $831.20. La antigüedad media del equipo directivo y de la junta directiva es de 1.9 años y 2.7 años, respectivamente.

Información clave

Bret Christensen

Chief Executive Officer (CEO)

US$1.9m

Compensación total

Porcentaje del salario del CEO20.2%
Permanencia del CEO1.2yrs
Participación del CEO0.007%
Permanencia media de la dirección2.5yrs
Promedio de permanencia en la Junta Directiva2.8yrs

Actualizaciones recientes de la dirección

Recent updates

DermTech, Inc. (NASDAQ:DMTK) Not Doing Enough For Some Investors As Its Shares Slump 44%

May 21
DermTech, Inc. (NASDAQ:DMTK) Not Doing Enough For Some Investors As Its Shares Slump 44%

We're A Little Worried About DermTech's (NASDAQ:DMTK) Cash Burn Rate

Mar 02
We're A Little Worried About DermTech's (NASDAQ:DMTK) Cash Burn Rate

Investors Don't See Light At End Of DermTech, Inc.'s (NASDAQ:DMTK) Tunnel And Push Stock Down 28%

Mar 02
Investors Don't See Light At End Of DermTech, Inc.'s (NASDAQ:DMTK) Tunnel And Push Stock Down 28%

Revenues Working Against DermTech, Inc.'s (NASDAQ:DMTK) Share Price

Dec 28
Revenues Working Against DermTech, Inc.'s (NASDAQ:DMTK) Share Price

Companies Like DermTech (NASDAQ:DMTK) Could Be Quite Risky

Sep 18
Companies Like DermTech (NASDAQ:DMTK) Could Be Quite Risky

Can DermTech (NASDAQ:DMTK) Afford To Invest In Growth?

Jun 14
Can DermTech (NASDAQ:DMTK) Afford To Invest In Growth?

Need To Know: The Consensus Just Cut Its DermTech, Inc. (NASDAQ:DMTK) Estimates For 2023

May 10
Need To Know: The Consensus Just Cut Its DermTech, Inc. (NASDAQ:DMTK) Estimates For 2023

DermTech, Inc. (NASDAQ:DMTK) Not Doing Enough For Some Investors As Its Shares Slump 37%

May 06
DermTech, Inc. (NASDAQ:DMTK) Not Doing Enough For Some Investors As Its Shares Slump 37%

We're Keeping An Eye On DermTech's (NASDAQ:DMTK) Cash Burn Rate

Jan 16
We're Keeping An Eye On DermTech's (NASDAQ:DMTK) Cash Burn Rate

Analyst Forecasts Just Became More Bearish On DermTech, Inc. (NASDAQ:DMTK)

Nov 08
Analyst Forecasts Just Became More Bearish On DermTech, Inc. (NASDAQ:DMTK)

Will DermTech (NASDAQ:DMTK) Spend Its Cash Wisely?

Oct 11
Will DermTech (NASDAQ:DMTK) Spend Its Cash Wisely?

DermTech grants stock options

Oct 11

Diving Into DermTech

Sep 01

Earnings Release: Here's Why Analysts Cut Their DermTech, Inc. (NASDAQ:DMTK) Price Target To US$23.80

Aug 10
Earnings Release: Here's Why Analysts Cut Their DermTech, Inc. (NASDAQ:DMTK) Price Target To US$23.80

DermTech: Approaching An All Or Nothing Moment

Jun 13

We're Keeping An Eye On DermTech's (NASDAQ:DMTK) Cash Burn Rate

Jun 04
We're Keeping An Eye On DermTech's (NASDAQ:DMTK) Cash Burn Rate

DermTech - Taking A Second Look At The Growth Thesis

Mar 31

DermTech: Adoption Headwinds And Earnings Misses

Dec 23

Companies Like DermTech (NASDAQ:DMTK) Are In A Position To Invest In Growth

Dec 02
Companies Like DermTech (NASDAQ:DMTK) Are In A Position To Invest In Growth

Análisis de compensación del CEO

¿Cómo ha cambiado la remuneración de Bret Christensen en comparación con los beneficios de DermTech?
FechaCompensación totalSalarioIngresos de la empresa
Mar 31 2024n/an/a

-US$90m

Dec 31 2023US$2mUS$389k

-US$101m

Compensación vs. Mercado: La compensación total de Bret($USD1.93M) está por encima de la media de empresas de tamaño similar en el mercado US ($USD673.68K).

Compensación vs. Ingresos: Datos insuficientes para comparar la compensación de Bret con los resultados de la empresa.


CEO

Bret Christensen (53 yo)

1.2yrs

Permanencia

US$1,928,967

Compensación

Mr. Bret Christensen serves as Chief Executive Officer, President and Director at DermTech, Inc. since May 08, 2023. He serves as Director of Axena Health, Inc. Mr. Christensen had been Chief Commercial Of...


Equipo directivo

NombrePosiciónPermanenciaCompensaciónPropiedad
Bret Christensen
President1.2yrsUS$1.93m0.0072%
$ 268.7
Kevin Sun
CFO, Treasurer & Secretary4.8yrsUS$934.85k0.57%
$ 21.4k
Ray Akhavan
General Counsel3.5yrsUS$818.76k0.19%
$ 7.2k
Steve Kunszabo
Senior Director of Investor Relationsno datasin datossin datos
Jennifer Eilemberg
Chief Compliance Officer2yrssin datossin datos
Loren Clarke
Chief Medical Officer3.1yrssin datossin datos
Mark Aguillard
Chief Commercial Officerless than a yearsin datossin datos

2.5yrs

Permanencia media

52yo

Promedio de edad

Equipo directivo experimentado: El equipo directivo de DMTK se considera experimentado (2.5 años antigüedad media).


Miembros de la Junta

NombrePosiciónPermanenciaCompensaciónPropiedad
Bret Christensen
President1.2yrsUS$1.93m0.0072%
$ 268.7
Herman Rosenman
Independent Director4.9yrsUS$149.64k0.28%
$ 10.6k
Kirk Malloy
Independent Director2yrsUS$136.64k0.095%
$ 3.6k
Matthew Posard
Independent Chairman of the Board8yrsUS$188.64k0.35%
$ 13.2k
Mark Capone
Independent Director2yrsUS$139.64k0.082%
$ 3.1k
Cynthia Collins
Independent Director4.9yrsUS$156.64k0.20%
$ 7.4k
Nathalie Keraudy
Independent Director2.8yrsUS$134.64k0.093%
$ 3.5k

2.8yrs

Permanencia media

57yo

Promedio de edad

Junta con experiencia: La junta directiva de DMTK no se considera experimentada (2.7 años de permanencia promedio), lo que sugiere una nueva junta directiva.